A PriceWaterhouseCooper Report finds that funding for life sciences companies seems to be lagging that for other industries, with potential positive and negative implications.
Practice Fusion has closed on the final $15 million of its Series D round, bring the total capital invested in the company to $149 million. Good luck getting a nice return on that.
Dabo Health, which originally was invested in by the Mayo Clinic, has attracted $2 million in additional financing to support its product which helps providers track their performance on quality measures.
Telecom New Zealand is putting as much as $5 million into Vigil Wireless Monitoring, which has a wristband that monitors and communicates biometric readings.
According to a survey reported in VentureBeat, half of angel investors regret an investment they made, usually because of overly optimistic financial projections. Angel investing is important to innovation, as they put $20 billion into companies a year, so hopefully the disappointment doesn't lead to closed wallets.
Validic has raised about $750,000 to create a product to gather and analyze data from various personal health activity devices, such as FitBit and Withings.
Scanadu has raised $10.5 million to continue to develop and sell its device that records various biometrics and uses software to help store, analyze and communicate the results. More frenzied app hype.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.